Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
High mobility group box 1 pseudogene 40 (HMGB1P40) is a human pseudogene encoding a DNA segment homologous to the functional high mobility group box 1 (HMGB1) gene[5]. Pseudogenes are nonfunctional gene relatives usually unable to generate active proteins due to disabling mutations or the lack of proper gene regulation[2][8]. There is no evidence that HMGB1P40 is transcribed or translated to a functional protein, nor any indication it acts as a therapeutic target, biomarker, or disease mediator. HMGB1P40 should be distinguished from the functional HMGB1 gene, which is widely studied for its roles in DNA binding, cellular stress response, and inflammation[1][3][6]. HMGB1P40’s sequence may complicate gene studies through amplification bias[2], but it is currently not considered of biological or pharmacological relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on High mobility group box 1 pseudogene 40 (HMGB1P40).